Nomura Holdings Inc Horizon Therapeutics Public LTD CO Transaction History

Nomura Holdings Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $14 Million - $16.3 Million	-140,966 Reduced 36.06%	250,000 $28.9 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $36.4 Million - $42.4 Million	377,736 Added 2855.15%	390,966 $40.2 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $1.42 Million - $1.5 Million	13,230 New	13,230 $1.44 Million
Q3 2022 Nov 15, 2022	BUY	$58.92 - $84.67 $23.8 Million - $34.2 Million	404,500 New	404,500 $25.1 Million
Q1 2022 May 18, 2022	SELL	$86.42 - $109.81 $769,483 - $977,748	-8,904 Closed	0 $0

Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $20.4 Million - $24.9 Million	-207,396 Reduced 95.88%	8,904 $960,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $19.9 Million - $23.9 Million	216,300 New	216,300 $23.8 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $3.08 Million - $3.43 Million	-35,750 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $1.31 Million - $1.74 Million	18,250 Added 104.29%	35,750 $3.29 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $1.17 Million - $1.48 Million	17,500 New	17,500 $1.28 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.